NDC 51662-1706-2 - EPINEPHRINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1706
- Requested NDC
- 51662-1706-2
- Package NDCs from labels
- 51662-1706-1, 51662-1706-2, 51662-1706-3
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2026-08-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| EPINEPHRINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2026-08-03 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| epinephrine | EPINEPHRINE | GLENMARK PHARMACEUTICALS INC., USA | cc4ebb51-6020-4339-a36a-ec2380b7d28e | 2026-11-03 | Warnings, Adverse reactions | 310132 1660014 YKH834O4BH |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Henry Schein, Inc. | e0e621d2-10b0-4cdf-b31d-c19b1e86ba6b | 2026-11-02 | Warnings, Adverse reactions | YKH834O4BH |
| EPINEPHRINE | EPINEPHRINE | Henry Schein, Inc. | 3b1ac82f-6920-4e40-a77e-598398679f2d | 2026-10-28 | Warnings, Adverse reactions | YKH834O4BH |
| epinephrine | EPINEPHRINE | Gland Pharma Limited | 577f987e-d3af-4f49-ab44-5db9cbf46601 | 2026-10-27 | Warnings, Adverse reactions | 310132 YKH834O4BH |
| Adrenalin | EPINEPRINE | Henry Schein, Inc. | b293ad8e-7055-4a95-a130-9d7d74f19eab | 2026-10-22 | Warnings, Adverse reactions | 1660014 YKH834O4BH |
| Epinephrine | EPINEPHRINE | Sportpharm LLC | a8e98483-9404-43bc-8800-b827c63c5134 | 2026-10-12 | Warnings, Adverse reactions | YKH834O4BH |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Henry Schein, Inc. | 5692e28d-559c-4b6a-8421-fa85d7155818 | 2026-10-05 | Warnings, Adverse reactions | YKH834O4BH |
| epinephrine | EPINEPHRINE | Gland Pharma Limited | 79ca73ca-d3c0-40af-9dec-e2f4ce669cda | 2026-09-23 | Warnings, Adverse reactions | 310132 1660014 YKH834O4BH |
| Auvi-Q | EPINEPHRINE | Sportpharm LLC | 5f40988b-8365-4f7b-84d1-b88e053725cf | 2026-09-18 | Warnings, Adverse reactions | YKH834O4BH |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Hospira, Inc. | 2f94f711-14c4-48ec-c5a3-c5ec4b8e8729 | 2026-09-17 | Warnings, Adverse reactions | YKH834O4BH |
| epinephrine | EPINEPHRINE | REMEDYREPACK INC. | bfc7ab3d-1e0e-4fd9-b6df-09603eb5808c | 2026-09-17 | Warnings, Adverse reactions | YKH834O4BH |
| Tree Pollen | ACER NEGUNDO, ACER RUBRUM, ADRENALINUM, ALLIUM CEPA, ARSENICUM IODATUM, BETULA NIGRA, EUPHRASIA OFFICINALIS, FRAXINUS AMERICANA, HISTAMINUM HYDROCHLORICUM, LIGUSTRUM VULGARE, LIQUIDAMBAR STYRACIFLUA, MORUS ALBA, PINUS STROBUS, POPULUS DELTOIDES, QUERCUS RUBRA, SABADILLA, SALIX NIGRA, SANGUINARIA CANADENSIS | NaturalCare | feea837e-7ce3-4575-8cb8-451f5385cf97 | 2026-09-03 | Warnings | YKH834O4BH |
| EPINEPHRINE | EPINEPHRINE | REMEDYREPACK INC. | 55befbe4-c819-4367-bbe7-de5841786aac | 2026-09-03 | Warnings, Adverse reactions | 1660014 YKH834O4BH |
| Adrenal Support | ADRENALINUM, ARGENTUM NITRICUM, BERBERIS VULGARIS, NATRUM MURIATICUM, OLEUM MORRHUAE, PETROLEUM, VANADIUM | NaturalCare | 31a5d522-15cd-432a-bf87-f721bcbe2e31 | 2026-09-02 | Warnings | YKH834O4BH |
| EPINEPHRINE | EPINEPHRINE | REMEDYREPACK INC. | 5ba14408-c8fb-4734-aad9-ee19696acac2 | 2026-08-28 | Warnings, Adverse reactions | NDA205029 1660014 YKH834O4BH |
| Allergy Care | ADRENALINUM, RAGWEED, POLLEN (AMBROSIA ARTEMISIAEFOLIA), APIS MELLIFICA, ECHINACEA (ANGUSTIFOLIA), HISTAMINUM HYDROCHLORICUM, LEDUM PALUSTRE, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, SULPHUR | NaturalCare | f3ca7f5a-1448-4670-ac02-b47ffb6c5585 | 2026-08-27 | Warnings | YKH834O4BH |
| Adrenal-Tone | ADRENALINUM, AVENA, GINKGO, GLYCYRRHIZA, KALI PHOS, NAT MUR, NUX VOMICA, PHOSPHORICUM AC, PITUITARUM POSTERIUM, SARSAPARILLA, THYROIDINUM, VERATRUM ALB, ZINC MET. | Energetix Corporation | 1ea4abb3-3a02-4d5c-baeb-d903b0febbb5 | 2026-08-11 | Warnings | YKH834O4BH |
| EPINEPHRINE | EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 5725a519-3ad6-7e5e-e063-6394a90a111f | 2026-08-10 | Warnings, Adverse reactions | 1660014 YKH834O4BH |
| EPINEPHRINE | EPINEPHRINE | HF Acquisition Co LLC, DBA HealthFirst | 5726eeca-db88-ba8e-e063-6294a90a927d | 2026-08-03 | Warnings, Adverse reactions | NDA205029 51662-1706-3 51662-1706-2 51662-1706-1 51662-1706 51662170602 1660014 582bb7c6-e26c-48e9-e063-6394a90a0fe7 5726eeca-db88-ba8e-e063-6294a90a927d YKH834O4BH |
| EPINEPHRINE | EPINEPHRINE | Fresenius Kabi USA, LLC | a6afb9e8-1db9-480c-8d31-58c5c870ca49 | 2026-07-29 | Warnings, Adverse reactions | 1660014 YKH834O4BH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.